Children Pain and Fever Reliver

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with the common cold, flu, headache, sore throat, and toothache. Additionally, it is indicated for the temporary reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This product is intended for use in specific populations, and healthcare professionals should refer to the dosage chart for appropriate dosing. It is essential to determine the correct dose based on the patient's weight or age, as outlined below.

For patients weighing under 24 lbs or under 2 years of age, consultation with a physician is required prior to administration. For those weighing between 24-35 lbs or aged 2-3 years, the recommended dose is 1 tablet. Patients weighing 36-47 lbs or aged 4-5 years should receive 1 ½ tablets. For individuals weighing 48-59 lbs or aged 6-8 years, the dose is 2 tablets. Patients weighing 60-71 lbs or aged 9-10 years should be administered 2 ½ tablets, while those weighing 72-95 lbs or aged 11 years and older may receive 3 tablets.

The product must be chewed completely before swallowing; it should not be swallowed whole. Dosing may be repeated every 4 hours as needed while symptoms persist, but it is critical not to exceed 5 doses within a 24-hour period. Healthcare professionals should ensure that patients do not receive more than the directed amount, as indicated in the overdose warning.

Contraindications

Use of this product is contraindicated in the following situations:

Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, is prohibited due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

This product should not be used in patients with a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation.

Additionally, it is essential to adhere to the recommended dosing guidelines, as exceeding the recommended dose may lead to serious adverse effects.

Warnings and Precautions

Severe liver damage may occur in pediatric patients taking this product, which contains acetaminophen, if they exceed the maximum daily dosage of 5 doses within a 24-hour period or if they are concurrently using other medications that also contain acetaminophen. Healthcare professionals should monitor patients closely for adherence to dosing guidelines to prevent potential hepatotoxicity.

Acetaminophen has been associated with the risk of severe skin reactions. Symptoms indicative of such reactions may include skin reddening, blistering, or rash. In the event of any skin reaction, it is imperative to discontinue use immediately and seek medical assistance without delay.

In cases of severe sore throat that persists for more than 2 days, or if it is accompanied or followed by additional symptoms such as fever, headache, rash, nausea, or vomiting, healthcare providers should be consulted promptly to rule out any serious underlying conditions.

Healthcare professionals should advise patients to discontinue use and seek medical advice if any of the following occur: worsening pain that lasts longer than 5 days, worsening fever that persists beyond 3 days, the emergence of new symptoms, or the presence of redness or swelling. These signs may indicate a serious medical condition requiring further evaluation.

In the event of an overdose, immediate medical attention is crucial. Patients or caregivers should be instructed to contact a Poison Control Center at 1-800-222-1222 without delay, even if no signs or symptoms are apparent, as prompt intervention is essential for patient safety.

Side Effects

Patients using this product should be aware of potential adverse reactions associated with acetaminophen.

Severe liver damage may occur if the maximum daily dosage of more than 5 doses in 24 hours is exceeded or if the product is taken concurrently with other medications containing acetaminophen. Patients with pre-existing liver disease should consult a healthcare professional prior to use.

An allergy alert is warranted, as acetaminophen may lead to severe skin reactions. Symptoms of such reactions can include skin reddening, blistering, and rash. Should any of these symptoms manifest, patients are advised to discontinue use immediately and seek medical assistance.

Patients should also be instructed to stop use and consult a doctor if pain worsens or persists beyond 5 days, if fever intensifies or lasts more than 3 days, if new symptoms arise, or if redness or swelling is observed, as these may indicate a serious underlying condition.

Additionally, it is recommended that patients taking the blood-thinning medication warfarin consult with a healthcare provider or pharmacist before using this product to avoid potential interactions.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may elevate the risk of bleeding, necessitating careful monitoring and potential dosage adjustments of either medication.

No additional drug interactions or laboratory test interactions have been identified for this medication.

Packaging & NDC

Below are the non-prescription pack sizes of Children Pain and Fever Reliver (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 to 11 years may be treated with this medication, with specific dosing recommendations based on weight. For children weighing under 24 lbs, consultation with a doctor is advised. For those weighing 24-35 lbs, the recommended dose is 1 tablet; for 36-47 lbs, 1 ½ tablets; for 48-59 lbs, 2 tablets; for 60-71 lbs, 2 ½ tablets; and for 72-95 lbs, 3 tablets. Doses may be repeated every 4 hours as needed, but should not exceed 5 doses in a 24-hour period.

Healthcare professionals should be aware of the potential for severe liver damage if a child exceeds 5 doses in 24 hours or if used concurrently with other acetaminophen-containing products. Additionally, acetaminophen may cause severe skin reactions, including symptoms such as skin reddening, blistering, or rash. If any skin reaction occurs, use should be discontinued immediately, and medical assistance should be sought.

In cases of severe sore throat that persists for more than 2 days or is accompanied by fever, headache, rash, nausea, or vomiting, prompt consultation with a doctor is recommended. It is also important to consult a doctor before use if the child has liver disease or is taking the anticoagulant warfarin. In the event of an overdose, immediate medical help or contact with a Poison Control Center is critical, even if no symptoms are present.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients. The prescribing information does not provide any recommended age considerations, dosage adjustments, safety concerns, or special precautions for elderly patients.

Healthcare providers should exercise clinical judgment when prescribing this medication to geriatric patients, considering the absence of data specific to this population. Monitoring for efficacy and safety is advised, as individual responses may vary.

Pregnancy

The safety of acetaminophen during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before using this product. While potential risks to the fetus are not clearly defined, caution is advised. There are no specific dosage modifications for pregnant individuals. It is recommended that the use of this product be discussed with a healthcare provider to ensure appropriate management and consideration of potential risks.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment should be closely monitored when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical that patients do not exceed five doses within a 24-hour period, as this represents the maximum daily amount. Additionally, patients must avoid concomitant use with other medications containing acetaminophen to prevent the risk of overdose and subsequent liver injury.

Before initiating treatment, it is advisable for caregivers to consult a healthcare professional if the patient has a history of liver disease. This precaution is essential to ensure the safe use of the product and to determine any necessary adjustments in dosing or monitoring based on the patient's liver function.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222. Prompt medical intervention is crucial, even in the absence of noticeable signs or symptoms. Healthcare professionals should be aware that early recognition and management of overdose can significantly impact patient outcomes.

It is essential to monitor the patient closely for any potential symptoms that may arise following an overdose. The specific manifestations can vary depending on the substance involved and the amount ingested. Therefore, a thorough assessment and appropriate supportive care should be initiated as soon as possible.

In summary, the key steps in managing an overdose include rapid communication with medical professionals and vigilant monitoring of the patient for any developing symptoms.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified rare cases of severe skin reactions associated with acetaminophen use. Reported symptoms include skin reddening, blistering, and rash. In instances where a skin reaction occurs, it is advised that the use of acetaminophen be discontinued and medical assistance be sought immediately.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 in the event of an overdose, emphasizing that prompt medical attention is crucial even if no signs or symptoms are apparent.

Patients should be informed not to use this product in conjunction with any other medications that contain acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in other medications, patients are encouraged to consult with a doctor or pharmacist.

It is important to instruct patients not to use this product if their child has a known allergy to acetaminophen or any of the inactive ingredients contained within the formulation.

Patients should be advised to discontinue use and consult a doctor if pain worsens or persists for more than 5 days, or if fever worsens or lasts longer than 3 days. Additionally, they should be instructed to seek medical advice if new symptoms arise or if there is any redness or swelling, as these may indicate a serious condition.

While using this product, patients must be cautioned against exceeding the recommended dosage, and they should be made aware of the overdose warning.

Healthcare providers should also recommend that patients consult a doctor before using this product if their child has liver disease. Furthermore, it is advisable for patients to speak with a doctor or pharmacist prior to use if their child is currently taking the blood-thinning medication warfarin.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature, ensuring that it is kept away from high humidity environments. Additionally, the product must be protected from light to maintain its integrity.

Healthcare professionals should refer to the end flap of the packaging for the expiration date and lot number, which are crucial for tracking and quality assurance purposes. Proper handling and storage conditions are vital to ensure the product's efficacy and safety.

Additional Clinical Information

The medication is administered orally, with a recommended repeat dose every 4 hours as long as symptoms persist. Clinicians should ensure that patients do not exceed 5 doses within a 24-hour period. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Children Pain and Fever Reliver, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)